Journals Current Treatment Options in G...

Current Treatment Options in Gastroenterology
Niel Dave, Enad Dawod, Okeefe L Simmons
PURPOSE OF REVIEW: Bariatric and metabolic endoscopic therapies provide an option for patients seeking clinically significant weight loss with fewer adverse events than conventional bariatric surgery. Our aims are to provide an overview of the current state of primary endoscopic treatment options for weight loss and to emphasize the importance of including these therapies when presenting weight loss options to qualified patients. RECENT FINDINGS: Bariatric endoscopy procedures are associated with a lower adverse event rate when compared to bariatric surgery and result in more weight loss than most existing pharmacotherapies approved by the Food and Drug Administration...
2023: Current Treatment Options in Gastroenterology
Christian Davis, Jennifer M Kolb
PURPOSE OF REVIEW: Endoscopic eradication therapy is an effective and durable treatment for Barrett's esophagus (BE) related neoplasia, but even after achieving successful eradication, these patients remain at risk for recurrence and require ongoing routine examinations. The optimal surveillance protocol including endoscopic technique, sampling strategy, and timing are still being refined. The aim of this review is to discuss current management principles for the post ablation patient and emerging technologies to guide clinical practice...
2023: Current Treatment Options in Gastroenterology
Amr M Arar, Kelli DeLay, David A Leiman, Paul Menard-Katcher
PURPOSE OF REVIEW: The purpose of this article is to discuss the diagnosis and treatment of diseases that affect both the skin and the esophagus. RECENT FINDINGS: The diagnosis of dermatological conditions that affect the esophagus often requires endoscopy and biopsy with some conditions requiring further investigation with serology, immunofluorescence, manometry, or genetic testing. Many conditions that affect the skin and esophagus can be treated successfully with systemic steroids and immunosuppressants including pemphigus, pemphigoid, HIV, esophageal lichen planus, and Crohn's disease...
December 2022: Current Treatment Options in Gastroenterology
Sabrina L Chen, Adam S Faye, Shannon Chang
PURPOSE OF REVIEW: Ileal pouch-anal anastomosis (IPAA) has become the preferred surgical treatment for patients with medically refractive ulcerative colitis (UC). Previous studies have suggested that outcomes of this procedure may be worse in older patients; however, more recent reports have suggested that IPAA in select patients is safe, feasible, and results in good quality of life. In this review, we discuss the recent literature surrounding clinical considerations and treatment management of IPAA in older adults...
December 2022: Current Treatment Options in Gastroenterology
Charlotte K Ching, Benjamin Lebwohl
PURPOSE OF REVIEW: This review highlights literature from the past several years and explores the impact on current understanding of celiac disease diagnosis, complications, and management in older adults. RECENT FINDINGS: Celiac disease in the elderly is becoming increasingly prevalent but remains underdiagnosed, with a high potential burden of downstream morbidity and modestly increased risk of mortality. Clinical presentations are often related to extraintestinal symptoms and can be subtle...
September 2022: Current Treatment Options in Gastroenterology
Adam S Faye, Tasnin Khan, Sandhya Cautha, Bharati Kochar
PURPOSE OF THE REVIEW: Sarcopenia is the loss of muscle quantity and strength. It is highly prevalent in patients with inflammatory bowel disease (IBD) and is associated with periods of ongoing inflammation. This review will summarize the prior work in the field and highlight areas for future research. RECENT FINDINGS: The presence of sarcopenia has been associated with adverse outcomes in different populations. Most recently, sarcopenia has been associated with adverse postoperative outcomes and an increased likelihood of surgery in IBD...
September 2022: Current Treatment Options in Gastroenterology
Luis Antonio Díaz, Gustavo Ayares, Jorge Arnold, Francisco Idalsoaga, Oscar Corsi, Marco Arrese, Juan Pablo Arab
Purpose of review: To assess the current challenges regarding liver diseases, including the burden of disease, access to care, screening, and treatment needs in Latin America. Recent findings: Latin America is a region with a rich multicultural heritage and important socioeconomic differences. The burden of liver diseases is high and mainly determined by a high level of alcohol intake and the surge of risk factors associated with NAFLD (i.e., sedentary lifestyles, broader access to highly processed foods, obesity, and type 2 diabetes mellitus)...
June 16, 2022: Current Treatment Options in Gastroenterology
Michelle D Dong, Shelley Steuwe, Lauren A Barry, Corey A Siegel
PURPOSE OF REVIEW: The COVID-19 pandemic helped us understand that telemedicine provides an alternative way to manage patients remotely, with an added benefit of saving time and travel costs. However, barriers may exist in an older population of patients such as inadequate technology availability and knowledge, and lack of internet connectivity. This systematic review and analysis of data at an academic medical center examines the current literature and investigates the efficacy of telemedicine for older adults requiring gastrointestinal care...
2022: Current Treatment Options in Gastroenterology
Yuying Luo, Brijen J Shah, Laurie A Keefer
PURPOSE OF REVIEW: The world's population is aging rapidly, with 40% of patients seen in US gastroenterology (GI) clinics being 60 years or older. Many gastrointestinal problems are more common or unique to the older adult because of progressive damage to the structure and function of the GI tract. Until recently, the epidemiology of disorders of gut-brain interaction (such as irritable bowel syndrome and functional dyspepsia) was not well-characterized. RECENT FINDINGS: Forty percent of persons worldwide have disorders of gut-brain interaction (DGBI), with varying global patterns of incidence in older adults...
2022: Current Treatment Options in Gastroenterology
Colleen Tewksbury, Kellene A Isom
PURPOSE OF REVIEW: Bariatric surgery is the most effective and durable treatment for severe obesity. Postoperative behavioral weight management approaches are available for optimizing weight change for both short- and long-term outcomes. RECENT FINDINGS: Varying settings such as groups and telemedicine along with techniques such as cognitive behavioral therapy have been assessed in the post-bariatric surgery population. The assessment and application of these programs have been limited due to methodological, financial, and attrition-related constraints...
2022: Current Treatment Options in Gastroenterology
Nneka N Ufere, Jan Hinson, Simon Finnigan, Elizabeth E Powell, John Donlan, Cathy Martin, Phil Clark, Patricia C Valery
PURPOSE OF REVIEW: To report social workers' involvement in supporting patients with cirrhosis. RECENT FINDINGS: Six intervention studies (three published in the past 3 years) highlighed the potential role of social worker-led interventions to improve the outcomes of patients with cirrhosis. In studies of patients with alcohol-related liver disease ( n  = 4), social workers conducted psychosocial assessments, screened for substance use disorder and psychological distress, coordinated referrals to addiction services, and provided relapse prevention therapy...
2022: Current Treatment Options in Gastroenterology
Alyson Kaplan, Russell Rosenblatt
PURPOSE OF THE REVIEW: Though it is well known that cirrhosis is associated with significant morbidity and mortality, management of symptoms in cirrhosis can be difficult. This review serves to offer practical guidance in the management of liver-specific symptoms of cirrhosis as well as other symptoms with special hepatic considerations. RECENT FINDINGS: We discuss liver-specific symptoms and management, including ascites and refractory ascites, hepatic encephalopathy, pruritus, and muscle cramping...
2022: Current Treatment Options in Gastroenterology
Rashid N Lui, Raymond S Y Tang, Philip W Y Chiu
PURPOSE OF REVIEW: This paper reviews the latest literature regarding the impact of COVID on endoscopy service provision. RECENT FINDINGS: Endoscopy has been shown to be largely safe when appropriate infection prevention and control measures are in place. Endoscopy training and education has been profoundly affected though novel training models to overcome this have been developed. Proper handling of delayed or cancelled procedures is of utmost importance to minimize delays in diagnosis and treatment of diseases such as cancer...
2022: Current Treatment Options in Gastroenterology
Chika Vera Anekwe, Michael G Knight, Sujatha Seetharaman, Wesley P Dutton, Shradha M Chhabria, Fatima Cody Stanford
PURPOSE OF REVIEW: We sought to critically evaluate the recent literature published over the past 3 years on the topic of weight regain after bariatric surgery in children, adolescents, and adults, with an emphasis on clinically- relevant information for pharmacologic treatment of weight regain after metabolic and bariatric surgery. FINDINGS: There are multiple pharmacotherapeutic agents available to treat obesity in children, adolescents, and adults; these agents have varying efficacy and indications for use and have been studied in a variety of clinical and research scenarios...
September 2021: Current Treatment Options in Gastroenterology
Yael R Nobel, Meaghan Phipps, Elizabeth C Verna
Purpose of review: The Coronavirus disease-2019 (COVID-19) pandemic has significantly impacted all aspects of liver transplantation. We reviewed the literature regarding COVID-19 clinical outcomes, treatment, and vaccination of liver transplant candidates and recipients. Recent findings: Patients with chronic liver disease, especially with cirrhosis, have higher morbidity and mortality from COVID-19 than patients without liver disease. Increased mortality has not been consistently seen in liver transplant recipients, in whom severe disease is more strongly associated advanced age and medical comorbidities, rather than with transplant-specific factors...
August 16, 2021: Current Treatment Options in Gastroenterology
T Tara Ghaziani, Renumathy Dhanasekaran
PURPOSE OF REVIEW: The management of advanced hepatocellular (HCC) has drastically changed in the past few years with approval of several first line and second line systemic therapies. In this review we present an overview of the recent progress in the treatment of advanced HCC and discuss future perspectives. RECENT FINDINGS: The phase 3 clinical trial IMBRAVE150 has recently shown the combination of an immune checkpoint inhibitor, atezolizumab, with an anti-angiogenic agent, bevacizumab, to be superior to sorafenib monotherapy for treatment-naive advanced HCC...
June 2021: Current Treatment Options in Gastroenterology
Akshata Moghe, Vera Yakovchenko, Timothy Morgan, Heather McCurdy, Dawn Scott, Karine Rozenberg-Ben-Dror, Shari Rogal
Purpose of review: This review provides an overview of the current state of research around improving healthcare delivery for patients with cirrhosis in the outpatient, inpatient, and transitional care settings. Recent findings: Recent studies have broadly employed changes to the model of care delivery, team composition, and technology to improve cirrhosis care. In the outpatient setting, approaches have included engaging caregivers, patient navigators, and non-physicians and using virtual care, smartphone applications, and wearables...
May 24, 2021: Current Treatment Options in Gastroenterology
Aisha Yusuf, Rebecca C Fitzgerald
Purpose of review: The targeted approach adopted for Barrett's oesophagus (BO) screening is sub-optimal considering the large proportion of BO cases that are currently missed. We reviewed the literature highlighting recent technological advancements in efforts to counteract this challenge. We also provided insights into strategies that can improve the outcomes from current BO screening practises. Recent findings: The standard method for BO detection, endoscopy, is invasive and expensive and therefore inappropriate for mass screening...
March 16, 2021: Current Treatment Options in Gastroenterology
Michael J Hall
Purpose of review: To critically examine recently published research in the area of chemoprevention in hereditary polyposis and gastrointestinal cancers, and to briefly review several ongoing chemoprevention trials testing novel agents in this population. Recent findings: Four recent chemoprevention trials in patients with familial adenomatous polyposis (FAP) were identified and reviewed. In the FAPEST trial, the combination of erlotinib+sulindac (compared to placebo) met its primary outcome of decreased duodenal polyp burden...
March 2021: Current Treatment Options in Gastroenterology
Hiroko Kawasaki, Yuko Akazawa, Nataliya Razumilava
Purpose of review: To provide an update on latest advances in treatment of cholangiocarcinoma. Recent findings: Incidence of cholangiocarcinoma has been increasing over the past decade. A better understanding of the genetic landscape of cholangiocarcinoma and its risk factors resulted in earlier diagnosis and treatment option expansion to targeted therapy with FGFR inhibitors, and liver transplantation for early perihilar cholangiocarcinoma and early intrahepatic cholangiocarcinoma...
March 2021: Current Treatment Options in Gastroenterology
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read

Save your favorite articles in one place with a free QxMD account.


Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.